2020
DOI: 10.3906/sag-2005-356
|View full text |Cite
|
Sign up to set email alerts
|

Melatonin, aging, and COVID-19: Could melatonin be beneficial for COVID-19 treatment in the elderly?

Abstract: The aim of this review is to summarize current studies on the relationship between melatonin and aging. Nowadays, age-related diseases come into prominence, and identifying age-related changes and developing proper therapeutic approaches are counted as some of the major issues regarding community health. Melatonin is the main hormone of the pineal gland. Melatonin is known to influence many biological processes in the body, including circadian rhythms, the immune system, and neuroendocrine and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(22 citation statements)
references
References 97 publications
0
20
0
2
Order By: Relevance
“…Melatonin levels decline considerably with aging, which is associated with several age-related diseases as oxidative damage and mitochondrial dysfunction. Studies focused on the relationship between melatonin and aging suggest an indirect antiviral effect [ 66 ] and the modulation of immune response and neuroinflammation caused by SARS-CoV-2 [ 67 ].…”
Section: Resultsmentioning
confidence: 99%
“…Melatonin levels decline considerably with aging, which is associated with several age-related diseases as oxidative damage and mitochondrial dysfunction. Studies focused on the relationship between melatonin and aging suggest an indirect antiviral effect [ 66 ] and the modulation of immune response and neuroinflammation caused by SARS-CoV-2 [ 67 ].…”
Section: Resultsmentioning
confidence: 99%
“…Melatonin, such as many other antiparasitic drugs-ivermectin [205][206][207][208][209], doxycycline [210][211][212], metronidazole [213], mefloquine [214], and hydroxychloroquine [215,216]has been suggested as a possible adjuvant agent in the treatment of coronavirus disease 2019 (COVID-19) infection [217][218][219][220][221]. Due to its anti-inflammatory, antioxidant and potent mitoprotective properties, melatonin might be beneficial in the preservation of mitochondrial functions and neuro-and cardioprotection during infections, whereas clarification of its mechanism of action as antiparasitic agent would be an interesting topic for further research.…”
Section: The Role Of Melatonin In the Treatment Of The Protozoan Parasitic Infectionsmentioning
confidence: 99%
“…The time spent on clinical trials, using a bioactive compound, such as melatonin, is not supported, due to the lack of protective patents for a natural compound ( 71 ). However, this obstacle has to be surpassed, not only due to its highly safe and effective profile, but also due to its multifactorial and synergic pharmacological actions ( 15 , 72 ).…”
Section: Clinical Trials Using Melatonin To Treat Covid-19mentioning
confidence: 99%